Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine - 12, 410 - 416 (2006)
Published online: 12 March 2006; | doi:10.1038/nm1377

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

Ju-Seog Lee1, Jeonghoon Heo1, Louis Libbrecht2, In-Sun Chu3, Pal Kaposi-Novak1, Diego F Calvisi1, Arsen Mikaelyan1, Lewis R Roberts4, Anthony J Demetris5, Zongtang Sun6, Frederik Nevens2, Tania Roskams2 & Snorri S Thorgeirsson1

1  Lab of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 4146, Bethesda, Maryland 20892, USA.

2  Departments of Morphology and Molecular Pathology, University of Leuven, Minderbroedersstraat 12, B-3000 Leuven, Belgium.

3  National Genome Information Center, Korea Research Institute of Bioscience and Biotechnology, 52 Eoeun-dong, Yuseong-gu, Taejun, 305-333, Korea.

4  Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.

5  Thomas E. Starzl Transplant Institute, University of Pittsburgh Medical Center, UPMC Montefiore E-741, 200 Lothrop Street, Pittsburgh, Pennsylvania 15213, USA.

6  National Laboratory of Molecular Oncology, Cancer Institute, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China.

Correspondence should be addressed to Snorri S Thorgeirsson snorri_thorgeirsson@nih.gov

The variability in the prognosis of individuals with hepatocellular carcinoma (HCC) suggests that HCC may comprise several distinct biological phenotypes. These phenotypes may result from activation of different oncogenic pathways during tumorigenesis and/or from a different cell of origin. Here we address whether the transcriptional characteristics of HCC can provide insight into the cellular origin of the tumor. We integrated gene expression data from rat fetal hepatoblasts and adult hepatocytes with HCC from human and mouse models. Individuals with HCC who shared a gene expression pattern with fetal hepatoblasts had a poor prognosis. The gene expression program that distinguished this subtype from other types of HCC included markers of hepatic oval cells, suggesting that HCC of this subtype may arise from hepatic progenitor cells. Analyses of gene networks showed that activation of AP-1 transcription factors in this newly identified HCC subtype might have key roles in tumor development.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
rights and permissionsRights and permissions
Order commercial reprintsOrder commercial reprints
CrossRef lists 56 articles citing this articleCrossRef lists 56 articles citing this article
Save this linkSave this link
Figures & Tables
Supplementary info
Export citation

Open Innovation Challenges

naturejobs

natureproducts

Search buyers guide:

 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2006 Nature Publishing Group | Privacy policy